QuidelOrtho's Management to Engage in Key Investor Events
QuidelOrtho Corporation (Nasdaq: QDEL), noted for its leadership in the field of in vitro diagnostics, has announced significant participation in upcoming investor conferences. This move reflects the company’s commitment to transparency and engagement with the investment community.
Upcoming Conferences and Participation Details
The management team at QuidelOrtho is set to take part in two notable investor gatherings that promise exciting discussions and insights:
Evercore ISI 8th Annual Healthcare Conference
On December 2, QuidelOrtho’s seasoned professionals will engage attendees in a compelling fireside chat scheduled for 10:00 a.m. ET / 7:00 a.m. PT. This session aims to provide investors with an in-depth look at the company's strategic direction and innovations in diagnostics.
Citi Global Healthcare Conference
The following day, December 3, the management team will again share insights during another fireside chat at 1:00 p.m. ET / 10:00 a.m. PT. This opportunity will give stakeholders a closer connection to the company's objectives and ongoing initiatives.
How to Access the Webcast
For those interested in tuning into these discussions, the live webcasts will be available in the "Events & Presentations" section of QuidelOrtho's Investor Relations webpage. This accessibility ensures that a wider audience can engage with QuidelOrtho's vision and upcoming projects.
QuidelOrtho's Commitment to Advancing Diagnostics
QuidelOrtho is passionately dedicated to enhancing diagnostics that contribute to healthier outcomes. As a pioneer in the industry, the company remains at the forefront of delivering innovative solutions that empower healthcare providers and patients alike.
Broader Impact on Patient Care
Through its ongoing efforts, QuidelOrtho demonstrates a robust commitment to providing fast, accurate, and reliable diagnostic results. Their solutions extend from the point of care to hospitals, laboratories, and clinics, significantly enhancing patient care and outcomes.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) boasts extensive expertise across various areas, including clinical chemistry, immunoassay, and molecular testing. The company’s innovations are not just products but part of a broader mission to connect healthcare insights with actionable solutions.
Driving Innovation in Healthcare
Building on a rich legacy, QuidelOrtho collaborates closely with healthcare providers to ensure they have the necessary tools to draw insights that lead to better clinical decisions and enhanced care standards. This approach solidifies its role as a prominent player in the diagnostics field.
Investor and Media Contact Information
For inquiries regarding investor relations, interested parties can reach out to Juliet Cunningham, Vice President of Investor Relations. For media inquiries, D. Nikki Wheeler Serves as the Senior Director of Corporate Communications.
Frequently Asked Questions
What is QuidelOrtho Corporation?
QuidelOrtho Corporation is a leading global provider of diagnostic solutions focused on advancing healthcare through innovative technologies.
What investor conferences is QuidelOrtho participating in?
QuidelOrtho will participate in the Evercore ISI 8th Annual Healthcare Conference and the Citi Global Healthcare Conference.
How can I access the conferences online?
The webcasts for the conferences will be available on QuidelOrtho’s Investor Relations webpage under the "Events & Presentations" section.
What is the main focus of QuidelOrtho?
The main focus of QuidelOrtho is to innovate and deliver reliable diagnostic solutions to improve patient outcomes.
Who can I contact for investor inquiries?
For investor inquiries, you can contact Juliet Cunningham, the Vice President of Investor Relations at QuidelOrtho.
